Ceftazidime, Avibactam

6 trials 2 recruiting JAnti-infectives

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

2 Recruiting

0 Completed trials

5 Sponsors

5 Countries

Phase III

Phase IV

Phase III: 1 Phase IV: 5

Indications tested

Antibiotic level therapeutic 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 2 Centre Hospitalier Universitaire De Nantes 1 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 1 National University Of Singapore 1 UZ Leuven 1

All trials

6 total

Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis Pending

2024-516849-39-01 Phase III 1 country Assistance Publique Hopitaux De Paris
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics (RAPID) Pending

2024-520067-13-00 Phase IV 1 country National University Of Singapore
Optimal Duration of Antibiotic Therapy in Drained Pyogenic Liver Abscess: 3 weeks versus 6 weeks, a non-inferiority trial Pending

2025-520940-14-00 Phase IV 1 country Assistance Publique Hopitaux De Paris
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting

2023-508441-41-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
Development of an optimized dosing regimen of ceftazidime-avibactam in critically ill patients treated with continuous renal replacement the… Recruiting

2023-505536-35-00 Phase IV 3 countries UZ Leuven

Showing 1–6 of 6 trials

← All drugs A–Z